The data showed that ANRIL is a better diagnostic indicator than cardiac troponin I in patients with stable angina and that the levels of ANRIL are higher in patients with stable angina than those with the myocardial infarction. The gene discussed is CDKN2B-AS1; the disease is myocardial infarction.